Showing results (41-50 of 121) with videos related to
Sort By:
Pageof 13
Journal of Cancer Research and Clinical Oncology|February 21, 2021
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in ChinaYang Wang, Bin Lian, Lu Si, et al.Translational Oncology|November 22, 2020
Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapyXuan Wang, Weiran Xu, Zhihong Chi, et al.Oncology Letters|September 21, 2017
Mutations in BRAF codons 594 and 596 predict good prognosis in melanomaXiaowen Wu, Junya Yan, Jie Dai, et al.Journal of Hematology & Oncology|January 5, 2018
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patientsJiayi Yu, Xiaowen Wu, Junya Yan, et al.Urologic Oncology|December 28, 2025
Disitamab vedotin with or without PD-1 inhibitors in pretreated patients with locally advanced or metastatic urothelial carcinoma: Identifying patients who derive additional benefit from immune combination therapyMengnan Qu, Jinchang Wei, Jiazhi Mo, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2013
A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanomaChuanliang Cui, Lili Mao, Zhihong Chi, et al.Journal of Cancer Research and Clinical Oncology|November 30, 2017
Analysis of TSC1 mutation spectrum in mucosal melanomaMeng Ma, Jie Dai, Tianxiao Xu, et al.Melanoma Research|August 8, 2018
Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeuticsJunya Yan, Xiaowen Wu, Jiayi Yu, et al.Dermatology Practical & Conceptual|February 16, 2024
Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective StudyYu Du, Zhonghui Qi, Xianbin Liang, et al.Chinese Clinical Oncology|September 6, 2018
Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case reportBixia Tang, Xinan Sheng, Yan Kong, et al.Pageof 13